1. Home
  2. MDGL vs AA Comparison

MDGL vs AA Comparison

Compare MDGL & AA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • AA
  • Stock Information
  • Founded
  • MDGL 2011
  • AA 1888
  • Country
  • MDGL United States
  • AA United States
  • Employees
  • MDGL N/A
  • AA N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • AA Aluminum
  • Sector
  • MDGL Health Care
  • AA Industrials
  • Exchange
  • MDGL Nasdaq
  • AA Nasdaq
  • Market Cap
  • MDGL 6.8B
  • AA 6.5B
  • IPO Year
  • MDGL N/A
  • AA 2016
  • Fundamental
  • Price
  • MDGL $282.86
  • AA $29.62
  • Analyst Decision
  • MDGL Strong Buy
  • AA Buy
  • Analyst Count
  • MDGL 10
  • AA 10
  • Target Price
  • MDGL $420.63
  • AA $40.00
  • AVG Volume (30 Days)
  • MDGL 382.7K
  • AA 7.3M
  • Earning Date
  • MDGL 05-01-2025
  • AA 04-16-2025
  • Dividend Yield
  • MDGL N/A
  • AA 1.35%
  • EPS Growth
  • MDGL N/A
  • AA N/A
  • EPS
  • MDGL N/A
  • AA 3.61
  • Revenue
  • MDGL $317,383,000.00
  • AA $12,665,000,000.00
  • Revenue This Year
  • MDGL $264.55
  • AA $9.04
  • Revenue Next Year
  • MDGL $67.21
  • AA N/A
  • P/E Ratio
  • MDGL N/A
  • AA $8.20
  • Revenue Growth
  • MDGL N/A
  • AA 20.85
  • 52 Week Low
  • MDGL $200.08
  • AA $21.53
  • 52 Week High
  • MDGL $377.46
  • AA $47.77
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 35.76
  • AA 63.17
  • Support Level
  • MDGL $287.46
  • AA $24.15
  • Resistance Level
  • MDGL $307.54
  • AA $25.88
  • Average True Range (ATR)
  • MDGL 16.58
  • AA 0.82
  • MACD
  • MDGL -2.70
  • AA 0.76
  • Stochastic Oscillator
  • MDGL 3.19
  • AA 96.17

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About AA Alcoa Corporation

Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.

Share on Social Networks: